Prevention of Pegfilgrastim-Induced Bone Pain: A Phase III Double-Blind Placebo-Controlled Randomized Clinical Trial of the University of Rochester Cancer Center Clinical Community Oncology Program Research Base

PURPOSE: Pegfilgrastim-induced bone pain is a significant clinical problem that may result in discontinuation of pegfilgrastim and lead to less effective chemotherapy dosing. Interventions for pegfilgrastim-induced bone pain are needed. PATIENTS AND METHODS: The University of Rochester Cancer Center...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kirshner, Jeffrey J., Heckler, Charles E., Janelsins, Michelle C., Dakhil, Shaker R., Hopkins, Judith O., Coles, Charlotte, Morrow, Gary R.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2012
Témata:
ORIGINAL REPORTS
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3383174/
https://ncbi.nlm.nih.gov/pubmed/22508813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.37.8364
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky